ID   Z354C_HUMAN             Reviewed;         554 AA.
AC   Q86Y25; Q6P4P9; Q8NFX1;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   03-MAY-2023, entry version 163.
DE   RecName: Full=Zinc finger protein 354C;
DE   AltName: Full=Kidney, ischemia, and developmentally-regulated protein 3;
DE            Short=hKID3;
GN   Name=ZNF354C; Synonyms=KID3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Kidney;
RX   PubMed=15555547; DOI=10.1016/j.bbrc.2004.10.158;
RA   Gao L., Sun C., Qiu H.-L., Liu H., Shao H.-J., Wang J., Li W.-X.;
RT   "Cloning and characterization of a novel human zinc finger gene, hKid3,
RT   from a C2H2-ZNF enriched human embryonic cDNA library.";
RL   Biochem. Biophys. Res. Commun. 325:1145-1152(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LYS-250.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-554.
RA   Gou D.-M., Li W.-X., Gao L., Sun Y.;
RT   "A novel zinc finger gene, KID3.";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-111; LYS-167; LYS-198 AND
RP   LYS-531, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May function as a transcription repressor. Binds to 5'-CCACA-
CC       3' core sequence. Suppresses osteogenic effects of RUNX2. May be
CC       involved in osteoblastic differentiation (By similarity). Plays a role
CC       in postnatal myogenesis, may be involved in the regulation of satellite
CC       cells self-renewal (By similarity). {ECO:0000250|UniProtKB:Q571J5,
CC       ECO:0000250|UniProtKB:Q9EPU7, ECO:0000269|PubMed:15555547}.
CC   -!- SUBUNIT: Interacts with RUNX2. Binds consensus element OSE2 (By
CC       similarity). {ECO:0000250|UniProtKB:Q9EPU7}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15555547}.
CC   -!- TISSUE SPECIFICITY: Expressed in kidney and skeletal muscle. Very low
CC       expression in brain and heart. {ECO:0000269|PubMed:15555547}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in brain. Very low expression in lung
CC       and liver. {ECO:0000269|PubMed:15555547}.
CC   -!- DOMAIN: KRAB domain is not required for nuclear targeting or for DNA
CC       binding. {ECO:0000250|UniProtKB:Q9EPU7}.
CC   -!- DOMAIN: Zinc finger region is involved in nuclear targeting and DNA-
CC       binding. {ECO:0000250|UniProtKB:Q9EPU7}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH63312.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF525463; AAO83897.1; -; mRNA.
DR   EMBL; BC063312; AAH63312.1; ALT_FRAME; mRNA.
DR   EMBL; AF395540; AAM69676.1; -; mRNA.
DR   CCDS; CCDS4443.1; -.
DR   RefSeq; NP_055409.1; NM_014594.2.
DR   RefSeq; XP_016864898.1; XM_017009409.1.
DR   AlphaFoldDB; Q86Y25; -.
DR   SMR; Q86Y25; -.
DR   BioGRID; 119048; 28.
DR   IntAct; Q86Y25; 16.
DR   STRING; 9606.ENSP00000324064; -.
DR   GlyGen; Q86Y25; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q86Y25; -.
DR   PhosphoSitePlus; Q86Y25; -.
DR   BioMuta; ZNF354C; -.
DR   DMDM; 74762464; -.
DR   EPD; Q86Y25; -.
DR   jPOST; Q86Y25; -.
DR   MassIVE; Q86Y25; -.
DR   MaxQB; Q86Y25; -.
DR   PaxDb; Q86Y25; -.
DR   PeptideAtlas; Q86Y25; -.
DR   ProteomicsDB; 70354; -.
DR   Antibodypedia; 29471; 53 antibodies from 13 providers.
DR   DNASU; 30832; -.
DR   Ensembl; ENST00000315475.7; ENSP00000324064.6; ENSG00000177932.7.
DR   GeneID; 30832; -.
DR   KEGG; hsa:30832; -.
DR   MANE-Select; ENST00000315475.7; ENSP00000324064.6; NM_014594.3; NP_055409.1.
DR   UCSC; uc003mju.4; human.
DR   AGR; HGNC:16736; -.
DR   CTD; 30832; -.
DR   DisGeNET; 30832; -.
DR   GeneCards; ZNF354C; -.
DR   HGNC; HGNC:16736; ZNF354C.
DR   HPA; ENSG00000177932; Low tissue specificity.
DR   MIM; 619511; gene.
DR   neXtProt; NX_Q86Y25; -.
DR   OpenTargets; ENSG00000177932; -.
DR   PharmGKB; PA38184; -.
DR   VEuPathDB; HostDB:ENSG00000177932; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000162715; -.
DR   HOGENOM; CLU_002678_0_9_1; -.
DR   InParanoid; Q86Y25; -.
DR   OMA; STFIEHQ; -.
DR   OrthoDB; 3128539at2759; -.
DR   PhylomeDB; Q86Y25; -.
DR   TreeFam; TF350822; -.
DR   PathwayCommons; Q86Y25; -.
DR   Reactome; R-HSA-212436; Generic Transcription Pathway.
DR   SignaLink; Q86Y25; -.
DR   BioGRID-ORCS; 30832; 4 hits in 1163 CRISPR screens.
DR   ChiTaRS; ZNF354C; human.
DR   GenomeRNAi; 30832; -.
DR   Pharos; Q86Y25; Tdark.
DR   PRO; PR:Q86Y25; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q86Y25; protein.
DR   Bgee; ENSG00000177932; Expressed in cortical plate and 155 other tissues.
DR   Genevisible; Q86Y25; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IEA:InterPro.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   Gene3D; 6.10.140.140; -; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 11.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24393; ZINC FINGER PROTEIN; 1.
DR   PANTHER; PTHR24393:SF88; ZINC FINGER PROTEIN 485; 1.
DR   Pfam; PF01352; KRAB; 1.
DR   Pfam; PF00096; zf-C2H2; 10.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 11.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 7.
DR   SUPFAM; SSF109640; KRAB domain (Kruppel-associated box); 1.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 11.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 11.
PE   1: Evidence at protein level;
KW   DNA-binding; Isopeptide bond; Metal-binding; Nucleus; Reference proteome;
KW   Repeat; Repressor; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..554
FT                   /note="Zinc finger protein 354C"
FT                   /id="PRO_0000280408"
FT   DOMAIN          12..83
FT                   /note="KRAB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00119"
FT   ZN_FING         216..238
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         244..266
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         272..294
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         300..322
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         328..350
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         356..378
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         384..406
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         412..434
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         440..462
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         468..490
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         496..518
FT                   /note="C2H2-type 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   CROSSLNK        111
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        167
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        198
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        531
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         250
FT                   /note="E -> K (in dbSNP:rs17855823)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_031138"
FT   VARIANT         546
FT                   /note="F -> L (in dbSNP:rs1445846)"
FT                   /id="VAR_031139"
FT   VARIANT         553
FT                   /note="E -> K (in dbSNP:rs1445845)"
FT                   /id="VAR_031140"
FT   CONFLICT        375
FT                   /note="Q -> H (in Ref. 3; AAM69676)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        415
FT                   /note="N -> T (in Ref. 3; AAM69676)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   554 AA;  64847 MW;  3B95DED46CCECFFC CRC64;
     MAVDLLSAQE PVTFRDVAVF FSQDEWLHLD SAQRALYREV MLENYSSLVS LGIPFSMPKL
     IHQLQQGEDP CMVEREVPSD TRLGFKTWLE TEALPHRQDI FIEETSQGMV KKESIKDGHW
     DINFEEAVEF ESEIEEEQEK KPLRQMIDSH EKTISEDGNH TSLELGKSLF TNTALVTQQS
     VPIERIPNMY YTFGKDFKQN FDLMKCFQIY PGGKPHICNE CGKSFKQNLH LIEHQRIHTG
     EKPYKCNECE KTFSHRSSLL SHQRIHTGEK PYKCNECEKA FSNSSTLIKH LRVHTGEKPY
     RCRECGKAFS QCSTLTVHQR IHTGEKLYKC GECEKAFNCR AKLHRHQRIH TGEKPYKCSE
     CGKGYSQFTS LAEHQRFHTG EQLYTCLECG RTFTRIVTLI EHQRIHTGQK PYQCNECEKA
     FNQYSSFNEH RKIHTGEKLY TCEECGKAFG CKSNLYRHQR IHTGEKPYQC NQCGKAFSQY
     SFLTEHERIH TGEKLYKCME CGKAYSYRSN LCRHKKVHTK EKLYKWKEYG KPFICSSSLT
     QYQRFFKGDK AYEV
//
